Overview

PK and DPK of Lidocaine Dermal Products

Status:
Completed
Trial end date:
2020-05-15
Target enrollment:
Participant gender:
Summary
This is a bioequivalence study to compare lidocaine release between a brand name and generic skin patches in healthy adults.
Phase:
Early Phase 1
Details
Lead Sponsor:
University of Maryland
University of Maryland, Baltimore
Collaborator:
Food and Drug Administration (FDA)
Treatments:
Lidocaine